Cargando…
A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates
Placental malaria (PM) is a deadly syndrome most frequent and severe in first pregnancies. PM results from accumulation of Plasmodium falciparum-infected erythrocytes (IE) that express the surface antigen VAR2CSA and bind to chondroitin sulfate A (CSA) in the placenta. Women become PM-resistant over...
Autores principales: | Doritchamou, Justin YA, Renn, Jonathan P, Jenkins, Bethany, Mahamar, Almahamoudou, Dicko, Alassane, Fried, Michal, Duffy, Patrick E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959597/ https://www.ncbi.nlm.nih.gov/pubmed/35103596 http://dx.doi.org/10.7554/eLife.76264 |
Ejemplares similares
-
Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
por: Renn, Jonathan P., et al.
Publicado: (2021) -
Author Correction: Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
por: Renn, Jonathan P., et al.
Publicado: (2022) -
A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?
por: Doritchamou, Justin Y. A., et al.
Publicado: (2023) -
Placental malaria vaccine candidate antigen VAR2CSA displays atypical domain architecture in some Plasmodium falciparum strains
por: Doritchamou, Justin Y. A., et al.
Publicado: (2019) -
Designing a VAR2CSA-based vaccine to prevent placental malaria()
por: Fried, Michal, et al.
Publicado: (2015)